MET and Small-Cell Lung Cancer

Author： Gelsomino Francesco   Rossi Giulio   Tiseo Marcello  

Publisher： MDPI

E-ISSN： 2072-6694|6|4|2100-2115

ISSN： 2072-6694

Source： Cancers, Vol.6, Iss.4, 2014-10, pp. : 2100-2115

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines

By Hamilton Gerhard  

Marine Drugs, Vol. 12, Iss. 3, 2014-03 ,pp. : 1377-1389

MDPI

Access to resources Recommend Favorite

Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK

By Rothschild Sacha I.  

Cancers, Vol. 7, Iss. 2, 2015-05 ,pp. : 930-949

MDPI

Access to resources Recommend Favorite

The Role of STAT3 in Non-Small Cell Lung Cancer

By Harada Daijiro   Takigawa Nagio   Kiura Katsuyuki  

Cancers, Vol. 6, Iss. 2, 2014-03 ,pp. : 708-722

MDPI

Access to resources Recommend Favorite

Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer

By Klupczynska Agnieszka   Swiatly Agata   Hajduk Joanna   Matysiak Jan   Dyszkiewicz Wojciech   Pawlak Krystian   Kokot Zenon J.  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-03 ,pp. : 410-410

MDPI

Access to resources Recommend Favorite

Biochip-Based Detection of KRAS Mutation in Non-Small Cell Lung Cancer

By Kriegshäuser Gernot   Fabjani Gerhild   Ziegler Barbara   Zöchbauer-Müller Sabine   End Adelheid   Zeillinger Robert  

International Journal of Molecular Sciences, Vol. 12, Iss. 12, 2011-11 ,pp. : 8530-8538

MDPI

Access to resources Recommend Favorite